Table 4.
Cross-tabulation of antihypertensive therapy to T-score categories.
| Treatment | T-score | |||
|---|---|---|---|---|
| Normal | Osteopenia | Osteoporosis | Total | |
| No | 13 | 14 | 9 | 36 |
| 36.1% | 38.9% | 25% | ||
|
| ||||
| ACE | 22 | 16 | 17 | 55 |
| 40.0% | 29.1% | 30.9% | ||
|
| ||||
| ARB | 25 | 18 | 6 | 49 |
| 51.0% | 36.7% | 12.2% | ||
|
| ||||
| CCB | 24 | 47 | 25 | 96 |
| 25.0% | 49.0% | 26% | ||
|
| ||||
| β-Blocker | 18 | 22 | 14 | 54 |
| 33.3% | 40.7% | 25.9% | ||
| 1.8% | 2.2% | 1.4% | ||
|
| ||||
| Diuretics | 11 | 6 | 8 | 25 |
| 44.0% | 24.0% | 32% | ||
|
| ||||
| Combination | 358 | 389 | 270 | 1017 |
| 35.2% | 38.2% | 26.5% | ||
ACE: angiotensin-converting enzyme, ARB: angiotensin II receptor blockers, and CCB: calcium channel blockers.